A passive and objective measure of recognition memory in Mild Cognitive Impairment using Fastball memory assessment

Abstract

Background: As viable pharmacotherapies and blood biomarkers emerge for dementia treatment and screening there remains a great need for accurate, sensitive biomarkers of cognitive function.